Zinc Finger Nucleases in Cell and Gene Therapy
Cell and gene therapy rely heavily on accurate genome modification, making Zinc Finger Nuclease technology a valuable tool. ZFNs enable stable genetic changes in cells before they are introduced into patients.
Ex vivo cell editing is a common application. Cells are collected from the patient, genetically modified using ZFNs, and then reintroduced. This controlled environment allows careful screening of edited cells before clinical use.
ZFNs have been applied in therapies involving hematopoietic stem cells, where permanent genetic correction can benefit all descendant blood cells. This approach holds promise for treating blood-related genetic disorders.
The durability of ZFN-mediated edits is a key advantage, as corrected genes are passed on during cell division. This long-term effect reduces the need for repeated treatments.